Literature DB >> 31699523

Epidemiological profile of patients hospitalized with candiduria in the Central-Western region of Brazil.

Milena Melges Pesenti de Santana1, Hugo Dias Hoffmann-Santos1, Luciana Basili Dias1, Tomoko Tadano2, Abdon Salam Khaled Karhawi2, Valéria Dutra3, Stephano Luiz Cândido3, Rosane Christine Hahn4.   

Abstract

BACKGROUND: Candida yeasts are considered the main agents of nosocomial fungal infections. AIMS: This study aimed to establish the epidemiological profile of patients with candiduria hospitalized in the capital of the State of Mato Grosso, in the Central-Western region of Brazil.
METHODS: Patients from three private hospitals and a public hospital participated in the study. This was an observational and cross-sectional study including analysis of patients mortality. It was carried out from March to August 2015.
RESULTS: A total of 93 patients with candiduria were evaluated. Candida tropicalis was found most commonly (37.6%; n=35), followed by Candida albicans (36.6%; n=34), Candida glabrata (19.3%; n=18), psilosis complex (4.3%; n=4), Candida lusitaniae (1.1%; n=1) and Candida krusei (1.1%; n=1). Antibiotic therapy (100%) and the use of an indwelling urinary catheter (89.2%; n=83) were the most frequent predisposing factors. Antifungal treatment was given to 65.6% of the patients, and anidulafungin was the most used antifungal. Mortality rates were 48% higher among patients with candiduria who had renal failure. Micafungin was the antifungal most prescribed among the patients who died. Candidemia concomitant with candiduria occurred in eight (8.6%; n=8) cases. Considering the species recovered in the blood and urine, only one patient had genetically distinct clinical isolates.
CONCLUSIONS: Non-C. albicans Candida species were predominant, with C. tropicalis being the most responsible for most cases of candiduria.
Copyright © 2019 Asociación Española de Micología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Brasil; Brazil; Candiduria; Epidemiological profile; Infección nosocomial; Nosocomial infection; Perfil epidemiológico

Year:  2019        PMID: 31699523     DOI: 10.1016/j.riam.2019.04.006

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  2 in total

1.  Evaluation of a Novel Laboratory Candiduria Screening Protocol in the Intensive Care Unit.

Authors:  Zhengxin He; Chang Su; Yuwang Bi; Yan Cheng; Daxin Lei; Fukun Wang
Journal:  Infect Drug Resist       Date:  2021-02-10       Impact factor: 4.003

2.  Using in vivo transcriptomics and RNA enrichment to identify genes involved in virulence of Candida glabrata.

Authors:  Sanne Schrevens; Eric Durandau; Van Du T Tran; Dominique Sanglard
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.